Business
Remdesivir study by World Health Organisation casts doubt, disputed by Gilead Sciences Inc – 7NEWS.com.au
The antiviral medication was one of the drugs used to treat US President Donald Trump after his COVID-19 diagnosis.
Gilead Sciences Inc has questioned the findings of a World Health Organisation (WHO) study that concluded its COVID-19 drug remdesivir does not help patients who have been admitted to hospital.
The American company told Reuters the data appeared inconsistent, the findings were premature and that other studies had validated the drugs benefits.
In a blow to one of the few drugs being used to treat people with COVID-19, the WHO said on Thursday its Solidarity trial had concluded that remdesivir a…
-
Noosa News16 hours agoSee inside the hidden suburbs where Queensland investors really live
-
Noosa News16 hours agoBusiness expo sparks inspiration and connection
-
Noosa News15 hours agoThe best new books released in August, from Toni Jordan, Rhett Davis and more
-
Business14 hours agoWhy it’s time to buy Domino’s, Flight Centre, and WiseTech shares